ProQR Therapeutics N.V.
Price Action
Technical Summary
WEAKENINGProQR Therapeutics N.V. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 43), showing significant lag compared to the market leaders. Earnings contraction of 30% provides fundamental context to the price action. Investors should exercise caution due to high volatility (77% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.66 | -0.10% | BELOW |
| 50 SMA | $1.60 | +4.07% | ABOVE |
| 100 SMA | $1.63 | +1.78% | ABOVE |
| 150 SMA | $1.73 | -3.84% | BELOW |
| 200 SMA | $1.89 | -12.12% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is PRQR in an uptrend right now?
PRQR has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is PRQR overbought or oversold?
PRQR's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is PRQR outperforming the market?
PRQR has a Relative Strength (RS) Rating of 43 out of 99. PRQR is currently lagging the broader market.
Where is PRQR in its 52-week range?
PRQR is trading at $1.66, which is 54% of its 52-week high ($3.10) and 19% above its 52-week low ($1.33).
How volatile is PRQR?
PRQR has a Beta of 1.78 and 52-week volatility of 77%. It's more volatile than the S&P 500 - expect bigger swings.